Invention Grant
- Patent Title: Adjuvant chemotherapy for anaplastic gliomas
-
Application No.: US15292324Application Date: 2016-10-13
-
Publication No.: US09968569B2Publication Date: 2018-05-15
- Inventor: Rheal A. Towner , Robert A. Floyd
- Applicant: OKLAHOMA MEDICAL RESEARCH FOUNDATION
- Applicant Address: US OK Oklahoma City
- Assignee: OKLAHOMA MEDICAL RESEARCH FOUNDATION
- Current Assignee: OKLAHOMA MEDICAL RESEARCH FOUNDATION
- Current Assignee Address: US OK Oklahoma City
- Agency: Parker Highlander PLLC
- Main IPC: A61K31/15
- IPC: A61K31/15 ; A61K31/185 ; A61K45/06 ; A61K31/166 ; A61K31/175 ; A61K31/4748 ; A23L33/10 ; A61N5/10

Abstract:
The present invention involves the use of 2,4-disulfonyl phenyl tert-butyl nitrone (2,4-ds-PBN) in the treatment and prevention of gliomas. The 2,4-ds-PBN may be used alone or combined with other traditional chemo- and radiotherapies and surgery, to treat or prevent glioma occurrence, recurrence, spread, growth, metastasis, or vascularization.
Public/Granted literature
- US20170027891A1 ADJUVANT CHEMOTHERAPY FOR ANAPLASTIC GLIOMAS Public/Granted day:2017-02-02
Information query